• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Diagnocure Inc

+ Add to Watchlist

CUR:CN

0.1150 CAD 0.0050 4.55%

As of 11:59:19 ET on 11/21/2014.

Snapshot for Diagnocure Inc (CUR)

Open: 0.1250 Day's Range: 0.1150 - 0.1400 Volume: 34,350
Previous Close: 0.1100 52wk Range: 0.1000 - 0.2400 1-Yr Rtn: -45.24%

Stock Chart for CUR

No chart data available.
  • CUR:CN 0.1200
  • 1D
  • 1M
  • 1Y
0.1100
Interactive CUR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CUR

Current P/E Ratio (ttm) -
Estimated P/E(10/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.0500
Est. EPS (CAD) (10/2014) -
Est. PEG Ratio -
Market Cap (M CAD) 4.95
Shares Outstanding (M) 43.04
30 Day Average Volume 37,977
Price/Book (mrq) -
Price/Sale (ttm) 8.5287
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/16/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CUR

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for CUR

DiagnoCure Inc., a biopharmaceutical company, develops diagnostic tests, therapeutic vaccines, and therapies in the fields of genitourinary and breast cancers. The Company markets its products internationally.

Yves FradetChairman/President/Co-FounderFrederic BoivinSenior Dir:Finance & Admin
More Company Profile & Key Executives for CUR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil